Synthroidlevothyroxine

276,239 adverse event reports submitted to the FDA (1997–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Synthroid in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Synthroid adverse event reports by reporter sex
SexReports
Female209,292
Male50,449
Unknown357

By Age Group

View age group data as a table
Synthroid adverse event reports by reporter age group
Age groupReports
0-172,707
18-347,176
35-4922,361
50-6453,154
65-7443,483
75+42,164

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Synthroid. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Synthroid adverse event reports by reported outcome
OutcomeReports
Non-Serious110,410
Other Serious105,967
Hospitalization80,338
Death18,181
Life-Threatening9,427
Disability8,244

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Synthroid. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Synthroid adverse event reports by year
YearReports
19971
19982
20001
20011
20022
20031
20045,678
20056,022
20066,274
20076,353
20088,198
20098,929
201011,697
201112,718
201215,041
20139,851
201411,102
201516,315
201616,835
201715,456
201815,037
201914,922
202017,217
202115,388
202216,279
202314,415
202414,131
202514,853
2026 (partial)3,520

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Synthroid

In FDA adverse event reports that mention Synthroid, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026